What is the recommended acute management for a patient with an acute left middle cerebral artery infarct?

Acute Management of Left Middle Cerebral Artery Infarct

For an acute left MCA infarct, immediately assess eligibility for IV alteplase (0.9 mg/kg, max 90 mg) within 4.5 hours of symptom onset, followed by urgent evaluation for mechanical thrombectomy if large vessel occlusion is present.

Immediate Thrombolytic Therapy

The cornerstone of acute MCA infarct management is IV alteplase administration as quickly as possible within the therapeutic window 1. Time is critical—every minute of delay worsens outcomes.

Eligibility Criteria (Within 3 Hours)

• Age ≥18 years (no upper age limit)
• Any stroke severity, including severe strokes despite higher hemorrhage risk
• Blood pressure controllable to <185/110 mmHg
• Blood glucose >50 mg/dL
• Patients on antiplatelet monotherapy or dual therapy (aspirin + clopidogrel) remain eligible 1

Extended Window (3-4.5 Hours)

Alteplase remains indicated but exclude patients who are:

• 80 years old

• Taking oral anticoagulants
• NIHSS >25
• History of both diabetes AND prior stroke
• Imaging showing >1/3 MCA territory involvement 1

Dosing Protocol

Administer 0.9 mg/kg (maximum 90 mg) over 60 minutes, with 10% given as bolus over 1 minute 1. Do not delay treatment for additional diagnostic studies beyond non-contrast CT to rule out hemorrhage.

Post-Thrombolysis Monitoring

Critical monitoring requirements include 1:

• First 2 hours: BP and neurological checks every 15 minutes
• Next 6 hours: Every 30 minutes
• Until 24 hours: Hourly assessments
• Maintain BP ≤185/110 mmHg
• Delay nasogastric tubes, Foley catheters, and arterial lines unless absolutely necessary
• Obtain follow-up imaging at 24 hours before starting anticoagulants or antiplatelets

Endovascular Thrombectomy Consideration

Urgently obtain vascular imaging (CTA or MRA) to identify large vessel occlusion requiring mechanical thrombectomy 2. The 2015 AHA/ASA guidelines established endovascular therapy as standard for proximal occlusions, and this has been further refined in the 2026 update 3.

For M2 segment occlusions specifically, recent evidence shows follow-up infarct volume ≤15 ml predicts favorable outcomes, with volumes >40 ml associated with poor prognosis 4.

Management of Malignant Cerebral Edema

MCA infarcts carry significant risk of life-threatening cerebral edema, particularly when involving >50% of MCA territory or infarct volume >145 ml 5, 6.

Monitoring for Malignant Course

Watch for:

• Hypodensity >50% MCA territory on CT
• Infarct volume >70 ml on DWI-MRI (associated with 71.5% mortality without intervention) 7
• Progressive decline in consciousness within 2-5 days

Medical Management

If edema develops 8:

• Osmotherapy: Target serum osmolarity 315-320 mOsm/L
• Start with enteric glycerol; escalate to mannitol if inadequate response
• Consider hypertonic saline, THAM buffer, or barbiturates for refractory cases
• Hyperventilation provides temporary benefit only

Decompressive Hemicraniectomy

For patients <60 years with malignant MCA infarction, perform decompressive hemicraniectomy within 48 hours of symptom onset 5, 6. This reduces mortality from 80% to 32% and 66% of survivors achieve functional independence 8.

Interestingly, subacute peak edema (>96 hours) is associated with better outcomes than earlier peak swelling, suggesting delayed edema may indicate less severe injury 9.

Critical Pitfalls to Avoid

• Do not delay alteplase for additional imaging beyond non-contrast CT—vascular imaging can occur simultaneously or after thrombolytic initiation
• Do not withhold alteplase in patients on dual antiplatelet therapy; benefits outweigh increased hemorrhage risk 1
• Do not miss malignant MCA criteria—early recognition and surgical consultation are essential for patients <60 years
• Do not wait for clinical deterioration to consider hemicraniectomy; imaging criteria should drive decision-making within 48 hours

Hemorrhagic Transformation Management

If symptomatic hemorrhage occurs within 24 hours 1:

• Stop alteplase immediately
• Obtain CBC, PT/INR, aPTT, fibrinogen, type and cross
• Emergency non-contrast head CT
• Administer cryoprecipitate 10 units over 10-30 minutes
• Give tranexamic acid 1000 mg IV over 10 minutes
• Urgent hematology and neurosurgery consultation

The left hemisphere location carries additional implications for language function, making aggressive early intervention particularly important to preserve communication abilities and overall quality of life.